about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
95.01
2.25
(2.43%)
86,817
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..